Evidence map›Paper›PMID 33484008›Full record

ReviewImmunological reviews2021

Regulatory B cells: TIM-1, transplant tolerance, and rejection.

Aravind Cherukuri, Kanishka Mohib, David M Rothstein

Open access · hybridAbstract readReview
In one paragraph

Review in Immunological reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Cellular and Molecular Aspects of Chronic Rejection.Results and problems in cell differentiation · 2026
    Review
  5. The effect of TIM1Cell death discovery · 2025
    Article
  6. Article
  7. The effect of TIM1Cell death & disease · 2025
    Article
  8. Review
  9. Immune Landscape in Kidney Transplantation.Journal of inflammation research · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aravind CherukuriThomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Kanishka MohibThomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
David M RothsteinThomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0002-9455-7971
University of Pittsburgh · US

Funding

Translational Core (Expression Core)P01AI129880 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROTHSTEIN, DAVID M · 2018 to 2022
$9.4M
In Vivo Detection And Mechanisms Of Regulatory B Cell Function In TransplantationR01AI114587 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROTHSTEIN, DAVID M · 2015 to 2025
$4.1M
The role of TIM-1 and Regulatory B cells in Allograft ToleranceR01AI097361 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROTHSTEIN, DAVID M · 2012 to 2016
$1.9M
NIAID NIH HHS P01 AI129880NIAID NIH HHS R01 AI097361NIAID NIH HHS R01 AI114587
6 · The paper itself

Abstract

Regulatory B cells (Bregs) ameliorate autoimmune disease and prevent allograft rejection. Conversely, they hinder effective clearance of pathogens and malignancies. Breg activity is mainly attributed to IL-10 expression, but also utilizes additional regulatory mechanisms such as TGF-β, FasL, IL-35, and TIGIT. Although Bregs are present in various subsets defined by phenotypic markers (including canonical B cell subsets), our understanding of Bregs has been limited by the lack of a broadly inclusive and specific phenotypic or transcriptional marker. TIM-1, a broad marker for Bregs first identified in transplant models, plays a major role in Breg maintenance and induction. Here, we expand on the role of TIM-1

Indexed as

Autoimmune DiseasesB-Lymphocytes, RegulatoryAnimalsImmune ToleranceMiceSignal TransductionTransplantation ToleranceBiomarkerInterleukin 10 (IL-10)Regulatory B cells (Bregs)T cell immunoglobulin and mucin domain 1 (TIM-1)Transitional B cells (Tr B cells)Transplantation

Identifiers

PMID33484008
PMCPMC7968891
OpenAlexW3123813098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.